Estrogens, Conjugated (Premarin)

Trade Name : Premarin

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

TABLET, FILM COATED

Strength 0.3 mg/1

ESTROGENS, CONJUGATED Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Estrogens, Conjugated (Premarin) which is also known as Premarin and Manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. It is available in strength of 0.3 mg/1 per ml. Read more

Estrogens, Conjugated (Premarin) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA
  • See full prescribing information for complete boxed warning.
  • Estrogen-Alone Therapy
  • Estrogen Plus Progestin Therapy
  • No data
  • PREMARIN is a mixture of estrogens indicated for:
  • Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause ()
  • Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause ()
  • Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure ()
  • Treatment of Breast Cancer (for Palliation Only) in Appropriately Selected Women and Men with Metastatic Disease ()
  • Treatment of Advanced Androgen-Dependent Carcinoma of the Prostate (for Palliation Only) ()
  • Prevention of Postmenopausal Osteoporosis ()
  • Generally, when estrogen therapy is prescribed for a postmenopausal woman with a uterus, a progestin should be considered to reduce the risk of endometrial cancer n
  • A woman without a uterus does not need progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin .
  • Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.
  • PREMARIN may be taken without regard to meals.
  • Daily administration of 0.3, 0.45, 0.625, 0.9, and 1.25 mg (, , , , )
  • Cyclic administration of 0.3, 0.625, and 1.25 mg (, , )
  • Tablets: 0.3, 0.45, 0.625, 0.9, and 1.25 mg ()
  • PREMARIN therapy is contraindicated in individuals with any of the following conditions:
  • Undiagnosed abnormal genital bleeding ()
  • Known, suspected, or history of breast cancer except in appropriately selected patients being treated for metastatic diseases (, )
  • Known or suspected estrogen-dependent neoplasia (, )
  • Active DVT, PE, or a history of these conditions (, )
  • Active arterial thromboembolic disease (for example, stroke and MI), or a history of these conditions (, )
  • Known anaphylactic reaction or angioedema with PREMARIN ()
  • Known liver impairment or disease (, )
  • Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders ()
  • Known or suspected pregnancy (, )
  • No data
  • Estrogens increase the risk of gallbladder disease ()
  • Discontinue estrogen if severe hypercalcemia, loss of vision, severe hypertriglyceridemia or cholestatic jaundice occurs (, , , )
  • Monitor thyroid function in women on thyroid replacement therapy (, )
  • The following serious adverse reactions are discussed elsewhere in labeling:
  • Most common adverse reactions (u2265 5 percent) are: abdominal pain, asthenia, pain, back pain, headache, flatulence, nausea, depression, insomnia, breast pain, endometrial hyperplasia, leucorrhea, vaginal hemorrhage, and vaginitis. ()
  • To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or n
  • Data from a single-dose drug-drug interaction study involving conjugated estrogens and medroxyprogesterone acetate indicate that the pharmacokinetic disposition of both drugs is not altered when the drugs are coadministered. No other clinical drug-drug interaction studies have been conducted with conjugated estrogens.
  • Inducers and/or inhibitors of CYP3A4 may affect estrogen drug metabolism ()
  • No data
  • Nursing Mothers: Estrogen administration has been shown to decrease the quantity and quality of breast milk ()
  • Geriatric Use: An increased risk of probable dementia in women over 65 years of age was reported in the Women's Health Initiative Memory ancillary studies of the Women's Health Initiative (, )
  • Overdosage of estrogen may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness and fatigue, and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of PREMARIN therapy with institution of appropriate symptomatic care.
  • PREMARIN (conjugated estrogens tablets, USP) for oral administration contains a mixture of conjugated estrogens purified from pregnant mares' urine and consists of the sodium salts of water-soluble estrogen sulfates blended to represent the average composition of material derived from pregnant mares' urine. It is a mixture of sodium estrone sulfate and sodium equilin sulfate. It contains concomitant components as sodium sulfate conjugates, 17u03b1-dihydroequilin, 17u03b1 estradiol, and 17u03b2-dihydroequilin. Tablets for oral administration are available in 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg, and 1.25 mg strengths of conjugated estrogens.
  • PREMARIN 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg, and 1.25 mg tablets also contain the following inactive ingredients: calcium phosphate tribasic, carnauba wax, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, powdered cellulose, sucrose, and titanium dioxide. Each tablet strength contains the following colors:
  • PREMARIN tablets comply with USP Dissolution Test criteria, as outlined below:
  • No data
  • Long-term continuous administration of natural and synthetic estrogens in certain animal species increases the frequency of carcinomas of the breast, uterus, cervix, vagina, testis, and liver.
  • No data
  • No data
  • No data
  • See FDA-approved patient labeling ().
  • PREMARIN(prem-uh-rin)
  • (Conjugated estrogen tablets, USP)
  • Read this PATIENT INFORMATION before you start taking PREMARIN and read what you get each time you refill your PREMARIN prescription. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG u2013 LABEL
  • Pfizer
  • NDC 0046-1100-81
  • PREMARIN
  • 0.3 mg
  • 100 Tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG u2013 CARTON
  • Pfizer
  • NDC 0046-1100-91 n n
  • PREMARIN
  • 0.3 mg
  • Note: Dispense in tight (USP), child-resistant containers. This package not for household use.
  • 1,000 Tablets
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG u2013 BLISTER CARD
  • NDC 0046-1100-51
  • PROFESSIONAL SAMPLE - NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 0.3 mg
  • Blister card contains five 0.3 mg tablets
  • Rx only
  • PANELPACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.3 MG - POUCHES
  • NDC 0046-1100-51
  • PROFESSIONAL SAMPLE u2013 NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 0.3 mg
  • Visit us at www.PREMARIN.com
  • Package contains: 1 blister card of 5 tables
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.45 MG u2013 LABEL
  • Pfizer
  • NDC 0046-1101-81
  • PREMARIN
  • 0.45 mg
  • 100 Tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG u2013 LABEL
  • Pfizer
  • NDC 0046-1102-81
  • PREMARIN
  • 0.625 mg
  • 100 Tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG u2013 BOTTLE CARTON
  • Pfizer
  • NDC 0046-1102-91 n n
  • PREMARIN
  • 0.625 mg
  • Note: Dispense in tight (USP), child-resistant containers. This package not for household use.
  • 1,000 Tablets
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - BLISTER CARD
  • NDC 0046-1102-51
  • PROFESSIONAL SAMPLE - NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 0.625 mg
  • Blister card contains five 0.625 mg tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - POUCHES
  • NDC 0046-1102-51
  • PROFESSIONAL SAMPLE u2013 NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 0.625 mg
  • Package contains: 1 blister card of 5 tablets
  • Visit us at www.PREMARIN.com
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.625 MG - CARTON
  • NDC 0046-1102-51
  • PROFESSIONAL SAMPLE u2013 NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 0.625 mg
  • Package contains 10 pouches with 1 blister card of 5 tablets each
  • Visit us at www.PREMARIN.com
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 0.9 MG u2013 LABEL
  • Pfizer
  • NDC 0046-1103-81
  • PREMARIN
  • 0.9 mg
  • 100 Tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG u2013 LABEL
  • Pfizer
  • NDC 0046-1104-81
  • PREMARIN
  • 1.25 mg
  • 100 Tablets
  • Rx only
  • PRINCIPAL DISPLAY PANEL - 1.25 mg Tablet Bottle Carton
  • Pfizer
  • NDC 0046-1104-91
  • PREMARIN
  • 1.25 mg
  • Note: Dispense in tight (USP), child-resistant containers. This package not for household use.
  • 1,000 Tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG u2013 BLISTER CARD
  • NDC 0046-1104-51
  • PROFESSIONAL SAMPLE - NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 1.25 mg
  • Blister card contains five 1.25 mg tablets
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG - POUCHES
  • NDC 0046-1104-51
  • PROFESSIONAL SAMPLE - NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 1.25 mg
  • Package contains: 1 blister card of 5 tablets
  • Visit us at www.PREMARIN.com
  • Rx only
  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - 1.25 MG - CARTON
  • NDC 0046-1104-51
  • PROFESSIONAL SAMPLE - NOT FOR SALE
  • PREMARINn
  • (conjugated estrogens tablets, USP)
  • 1.25 mg
  • Package contains 10 pouches with 1 blister card of 5 tablets each
  • Visit us at www.PREMARIN.com
  • Rx only

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.